Cenobamate
Overview
Cenobamate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3989949).
API suppliers (8)
Suppliers of Cenobamate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 7 of 8 suppliers.
4 of 8 hold a GMP certificate on record in the EU or UK registers
- APICHEM Laboratories Private LimitedIndia1 active DMF
- BIOPHORE INDIA PHARMACEUTICALS PVT LTD1 active DMF
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
- METROCHEM API PRIVATE LTDIndia1 active DMF
- OPTIMUS DRUGS PRIVATE LTDIndia1 active DMF
- MAITHRI DRUGS PRIVATE LTDIndia1 active DMF GMP on record
- LEE PHARMA LTDIndia1 active DMF GMP on record
- AMI LIFESCIENCES PRIVATE LTDIndia1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (6 approved US products), the latest listed US patent on Cenobamate expires 16 Jun 2039. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate
- Canonical SMILES
- C1=CC=C(C(=C1)[C@H](CN2N=CN=N2)OC(=O)N)Cl
- InChIKey
- GFHAXPJGXSQLPT-VIFPVBQESA-N
Do you supply Cenobamate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.